InsidersTradesSigma
Discover the detailed record of transactions filed by Hung David, Director. Insider active across 1 companies, notably NovoCure Ltd. Aggregated, 3 disclosures have been logged. The latest transaction was disclosed on 8 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations
David Hung is a Director at NovoCure Ltd, a biotechnology company developing treatments for cancer. With extensive expertise in the healthcare sector, he contributes to the company's strategy and governance, ensuring that NovoCure's objectives are met while adhering to ethical and regulatory standards.